Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Roggenbuck

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2024
Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinomaChang-Sheng Xia, Marcin Krawczyk, Chun Di, et al.
Gut Microbes|October 6, 2025
First insights into microbial changes within an Inflammatory Bowel Disease Family Cohort studyPhilipp Rausch, Ilka Ratjen, Lukas Tittmann, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2024
Antimicrobial glycoprotein 2 (GP2) in gallstones, bile fluid and peribiliary glands of patients with primary sclerosing cholangitisSteffi Lopens, Peter Schierack, Jenny Krause, et al.
Clinical Chemistry and Laboratory Medicine|October 7, 2020
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paperXavier Bossuyt, Jan Damoiseaux, Niels Rasmussen, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2024
Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinomaChang-Sheng Xia, Marcin Krawczyk, Chun Di, et al.
Gut Microbes|October 6, 2025
First insights into microbial changes within an Inflammatory Bowel Disease Family Cohort studyPhilipp Rausch, Ilka Ratjen, Lukas Tittmann, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2024
Antimicrobial glycoprotein 2 (GP2) in gallstones, bile fluid and peribiliary glands of patients with primary sclerosing cholangitisSteffi Lopens, Peter Schierack, Jenny Krause, et al.
Clinical Chemistry and Laboratory Medicine|October 7, 2020
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paperXavier Bossuyt, Jan Damoiseaux, Niels Rasmussen, et al.
Pageof 15